Assessment of Dissociative Traumatic Disorders

Posttraumatic Stress Disorder Clinical Trial

— TEDI  

Official title:

Assessment of Dissociative Traumatic Disorders

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04379648
• Other study ID #: 10477M-TEDI
• Status: Recruiting
• Phase: N/A
• Start date: February 5, 2019
• Est. completion date: September 5, 2021

Study information

• Verified date: May 2020
• Source: Centre hospitalier de Ville-Evrard, France
• Contact: BENCHERIF Youcef, CRA
• Phone: 0143093030
• Email: y.bencherif[@]epsve.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

More than 70% of ambulatory patients with IDD have attempted suicide (APA, 2015). This disorder, as well as all the disorders on the dissociation spectrum, must therefore be clarified and better diagnosed.

The goal of this research is :

1. to assess the prevalence of dissociative disorders using specific tools in patients suffering from PTSD.

2. to validate the French version of the DDIS interview (Ross, 1997) that the investigators have translated.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: September 5, 2021
• Est. primary completion date: September 5, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient diagnosed with PTSD according to DSM 5 criteria

• Over 18 years of age

• Informed consent signed

Exclusion Criteria:

• Neurological disorders

• Serious and/or unstable somatic pathologies

• Patient not affiliated with social security

• Patient hospitalized under restraint in psychiatric care by decision of the state representative or in psychiatric care at the request of a third party

• Patient under guardianship

• Patient participating in parallel in another biomedical research

• Change of antidepressant in the last three months

• Patient not mastering the French language

Related Conditions & MeSH terms

• Posttraumatic Stress Disorder
• Stress Disorders, Post-Traumatic

Intervention

Other:
• self-assessment and hetero-assessment
Self assessment for the passing of the following rating scales CTQ-SF36-ITQ-PCL5-DES Hetero-assessment for the pasing of the following rating scales DDIS FR and medical interview

Locations

Country	Name	City	State
France	Youcef BENCHERIF	Neuilly Sur Marne	Île De France

Sponsors (1)

Lead Sponsor	Collaborator
Januel

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Post Traumatic Stress	assessment of the prevalence of dissociative disorders in a cohort of patients with PTSD	1 year